You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company receives close to 1 million SEK in a research grant from Swedish innovation agency, Vinnova, for developing a new treatment for genetic mitochondrial diseases. NeuroVive receives the grant from Vinnova's 2017 Swelife call to continue progressing the preclinical project NVP015. The cutAlready a subscriber Login You have read…
Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca. Shares in AstraZeneca fell 1.2 percent by 0800 GMT on Friday following the news. Pfizer is in the middle of a…
Until 2021, only researchers based in Denmark were eligible to receive the Novo Nordisk Foundation (NNF)'s grants under the Distinguished Innovator programme, but from 2022 researchers in any Nordic country (Denmark, Finland, Iceland, Norway and Sweden) are eligible. These grants support researchAlready a subscriber Login You have read all your…
A new Swedish cell and gene therapy company, Elicera Therapeutics, has announced that it has completed its first share issue and secured 13.2 MSEK in financing. The company is based on research by professor Magnus Essand's research group at Uppsala University and will focus on CAR T cells and oncAlready…
